FIELD: pharmacology.
SUBSTANCE: invention relates to application of 3-(1H-benzimidazol-2-yl)-1,2,2-trimethylcyclopentanecarboxylic acid as an agent having cardioprotective activity.
EFFECT: new properties of this acid are revealed that allow to increase the effectiveness of cardiovascular diseases treatment.
1 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
(±)-CIS-3-(2'-BENZIMIDAZOLYL)-1,2,2-TRIMETHYLCYCLO- PENTANE CARBOXYLIC ACID ELICITING SUGAR-REDUCING AND ANTIDIABETOGENIC EFFECT | 2000 |
|
RU2205826C2 |
5-POTASSIUM HYDROXINICOTINATE WITH CARDIOPROTECTIVE ACTIVITY | 2017 |
|
RU2640580C1 |
PHARMACEUTICAL ANTIDIABETIC COMPOSITION BASED ON (+)-CIS-3-(1H-BENZIMIDAZOL-2-YL)-1,2,2-TRIMETHYLCYCLOPENTANE CARBOXYLIC ACID | 2016 |
|
RU2624872C1 |
CARDIOPROTECTIVE PHARMACEUTICAL SUBSTANCE AND METHOD OF ITS PREPARATION | 2016 |
|
RU2629772C1 |
METHOD OF CARDIOPROTECTIVE ACTIVITY ESTIMATION OF PHARMACOLOGICAL FACILITIES | 2017 |
|
RU2643104C1 |
DERIVATIVES OF QUINAZOLINE-4 (3H)-ONE, WITH NEURO- AND CARDIOPROTECTIVE ACTIVITY | 2016 |
|
RU2622638C1 |
METHOD OF CORRECTION OF STREPTOZOTOCIN-INDUCED DIABETES MELLITUS IN RATS USING A HETEROCYCLIC AMIDE-BASED DRUG | 2018 |
|
RU2687979C1 |
PHARMACEUTICAL COMBINED PREPARATIONS | 1998 |
|
RU2222328C2 |
AGENT WITH ANTIHYPOXIC ACTIVITY | 2022 |
|
RU2797210C1 |
APPLICATION OF VASOPEPTIDASE INHIBITOR FOR TREATING STENOCARDIA | 2000 |
|
RU2245147C2 |
Authors
Dates
2018-02-21—Published
2017-08-15—Filed